Artelo Biosciences
ARTL
19 hedge funds and large institutions have $984K invested in Artelo Biosciences in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
27% more funds holding
Funds holding: 15 → 19 (+4)
0.01% less ownership
Funds ownership: 0.03% → 0.02% (-0.01%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
37% less capital invested
Capital invested by funds: $1.57M → $984K (-$585K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$101K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$37.1K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$20.1K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$18K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$127K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$97K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$41.1K |
| 4 |
Two Sigma Advisers
New York
|
-$14.4K |
| 5 |
LCM
LVM Capital Management
Portage,
Michigan
|
-$9K |
ARTL Hedge Fund Activity: Q4 2021 in Review
19 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q4 2021, worth a combined $984K — down 37% from $1.57M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ARTL positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Virtu Financial, adding an estimated $101K. The largest seller was Renaissance Technologies, cutting an estimated $127K.
- 19 institutional investors held Artelo Biosciences (ARTL) as of Q4 2021, up from 15 in Q3 2021.
- Funds reported $984K of Artelo Biosciences stock for Q4 2021, down 37% quarter-over-quarter.
- 7 funds opened new Artelo Biosciences positions in Q4 2021 and 3 closed out, a net change of +4 holders.
- The largest Artelo Biosciences buyer in Q4 2021 was Virtu Financial, an estimated $101K added.
- The largest Artelo Biosciences seller in Q4 2021 was Renaissance Technologies, an estimated $127K sold.
Based on aggregated 13F filings for Q4 2021.